Mesothelioma in the age of “Omics”: Before and after The Cancer Genome Atlas
Feature Editor's Introduction —Malignant pleural mesothelioma (MPM) is a highly fatal cancer of the pleura that has been defeating standard and investigational therapies since its first description. The efficacies of chemotherapy, radiotherapy, and surgical therapy are limited, and we have been writing for decades that improve d therapies are needed. MPM is born of inflammation, and approximately 80% of cases are associated with the smoldering tissue inflammatory responses against the carcinogenic fibers of asbestos.
Source: The Journal of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: David T. Severson, Assunta De Rienzo, Raphael Bueno Tags: Invited Expert Opinion Source Type: research
More News: Asbestosis | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Chemotherapy | Heart | Mesothelioma